Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
about
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studiesDesign and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas.DiAs user interface: a patient-centric interface for mobile artificial pancreas systemsArtificial pancreas: past, present, futureCurrent application of continuous glucose monitoring in the treatment of diabetes: pros and consContinuous subcutaneous insulin infusion in adult type 1 diabetes mellitus: data from a registry at the University Medical Centre Ljubljana, Slovenia.Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusionOutpatient-to-inpatient transition of insulin pump therapy: successes and continuing challenges.Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trialParental involvement buffers associations between pump duration and metabolic control among adolescents with type 1 diabetesAutomated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.Insulin pumpsFitting dynamic models with forcing functions: application to continuous glucose monitoring in insulin therapy.Use of sensors in the treatment and follow-up of patients with diabetes mellitus.Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients.Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomesAre late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps?Closed-loop insulin delivery in type 1 diabetes.Diabetic management in high risk patients (pregnancy, insulin pumps).A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.Feasibility of overnight closed-loop control based on hourly blood glucose measurements.Quality of life and technology: impact on children and families with diabetesAssessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?Using Remote Communication Technology in Insulin Pump Training: A Feasibility StudyClosed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.Continuous subcutaneous insulin infusion versus multiple daily injections.Predictors of diabetes-related quality of life after transitioning to the insulin pump.Assessing quality of life for new diabetes treatments and technologies: a simple patient-centered score.A review of the "bolus guide," a new insulin bolus dosing support tool based on selection of carbohydrate ranges.Closed-loop insulin delivery: from bench to clinical practice.Wearable and implantable pancreas substitutes.Continuous subcutaneous insulin infusion: practical issues.Use of technology when assessing adherence to diabetes self-management behaviors.Management of insulin pump therapy in children with type 1 diabetes.Advances in management of type 1 diabetes mellitus.Description and preliminary evaluation of a diabetes technology simulation course
P2860
Q28741005-964EC602-27BD-4111-9F10-B482D1681E82Q30370001-26CE94EF-8B3A-449E-AC2B-7A40FAACB2CCQ30409823-E515C950-71DE-47F0-B4C2-26EB1840AA50Q30424200-E06D3BD2-98C1-42CE-9101-9C9DFAAC0332Q30455250-43BDD8B6-71AF-4EB7-88D2-FEEF38673C1EQ30564482-F239F6C3-2113-4EB2-BE72-B4C7A970E8EAQ33789513-3F861CF1-956C-4192-8EBF-BB21DCDDF18EQ34018099-7A5035DB-6BB4-44F9-94A2-87381F40387BQ34119580-D5758F1E-EE2C-441B-82FF-22AAA1FA2654Q34151785-0078393F-6500-4F75-B276-568D0B5DB735Q34204140-836B5D2C-8228-45D9-99B5-FEC6E22DB9EAQ34444545-75BD1137-C168-4E6D-94BA-C5CDDA3B53DFQ34604619-E1953EF5-C9BA-433B-8FE1-8459E9A0B400Q35274358-E7AC2E5E-3BE7-408F-BED9-E232A4953625Q35447304-B28FD083-13F8-4C82-9F2E-884E8338F649Q35594010-D60D609E-707D-45C8-95BC-C8C20D70FA25Q35758485-38F9A66B-8A8B-4143-801D-22ED35AC5FB3Q35762308-95CD246C-4FE4-4FD4-A81A-D1D4930B8F16Q35879334-056B4D37-75CB-4178-A68D-A073A3474185Q35954124-5B97380A-26A5-4A69-AAAC-34761E53B88EQ35983217-AC9D8D41-658A-4DA7-BA03-7668C92D0059Q36076863-F9564501-7B22-4B70-A160-33A6B627D573Q36229333-2B03B84E-A80E-4FBF-831E-420252F4E462Q36464623-A2563982-F56F-4F77-878D-F0BA93C1D297Q36520578-5E003ED5-21E8-4992-8B04-85A535CBA970Q36554243-6AA30DCD-D4C1-4C2F-852B-29C3ED2A9A89Q36638894-AB74195E-F692-439F-9BB0-D7B0577A3C39Q36720273-BA384BA6-D75D-4D53-87B7-86A340DD5E71Q37122884-3B5C5130-D9B5-4C62-8FE6-683EC3DC1988Q37194898-5D8B9533-0F09-4E3C-8BEA-AD7C7C032B69Q37292608-CAC3832E-84D3-4465-8C16-7FFA9B09601EQ37403871-9F8B106A-C2A2-444D-9EEF-DC00363533F5Q37776036-01BB5E36-3510-4E96-ACE7-03D8BE9A6D72Q37846089-0D8AF4BF-E2BA-4EA0-91D5-8E3B7BCBCD6EQ38044675-1FBB20C3-E9F2-4AD5-9F7B-2AD5F11531D5Q38097040-240110EC-F2B7-4AB2-A701-975B0519C8C6Q38229366-8D3A6F1A-06C7-44CA-93FE-AA42347BD2C4Q38240114-55455E45-A703-42ED-AD40-D78A1E9D8C02Q38260399-8B3F6739-52FA-42D6-89C9-296F5AC7B594Q38423110-2C7E3018-892E-4270-809B-19B5AED2ADC2
P2860
Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@ast
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@en
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@nl
type
label
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@ast
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@en
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@nl
prefLabel
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@ast
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@en
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@nl
P356
P1433
P1476
Continuous subcutaneous insuli ...... mp therapy in type 1 diabetes.
@en
P2093
Harry Keen
John Pickup
P304
P356
10.2337/DIACARE.25.3.593
P407
P577
2002-03-01T00:00:00Z